In humans, homozygous or compound heterozygous loss-of-function mutations of TK2 associated with mitochondrial DNA depletion syndrome (MDS) result in 1–39% TK2 activity relative to healthy controls and typically manifest as infantile-onset severe myopathy [19]. This evidence concerns the gene TK2 and myopathy.